Showing 1 - 7 results of 7 for search 'Si-Man Ieong', query time: 0.03s Refine Results
  1. 1
    Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations

    Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations by Aristine Cheng, Ming-Ju Hsieh, Sui-Yuan Chang, Si-Man Ieong, Chien-Yu Cheng, Wang-Huei Sheng, Shan-Chwen Chang

    Published 2023-05-01
    Get full text
    Article
  2. 2
    Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

    Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan by Wang-Huei Sheng, Chung-Cheng Wang, Ching-Chi Chu, Yueh-Juh Lin, Sui-Yuan Chang, Si-Man Ieong, Shan-Chwen Chang

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021

    Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021 by Kuan-Yin Lin, Ming-Ju Hsieh, Sui-Yuan Chang, Si-Man Ieong, Chien-Yu Cheng, Wang-Huei Sheng, Shan-Chwen Chang

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

    Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets by Pei-Chen Yu, Chen-Hao Huang, Chih-Jung Kuo, Po-Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan, Sui-Yuan Chang, Tai-Ling Chao, Si-Man Ieong, Jun-Tung Fang, Hsuan-Cheng Huang, Hsueh-Fen Juan

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination

    Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination by Wang-Huei Sheng, Sui-Yuan Chang, Pin-Hung Lin, Ming-Ju Hsieh, Hao-Hsiang Chang, Chien-Yu Cheng, Hung-Chih Yang, Ching-Fu Pan, Si-Man Ieong, Tai-Ling Chao, Jang-Pin Chen, Shu-Hsing Cheng, Shan-Chwen Chang

    Published 2022-04-01
    Get full text
    Article
  6. 6
    Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19

    Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19 by Wang-Da Liu, Jann-Tay Wang, Tai-Ling Chao, Si-Man Ieong, Ya-Min Tsai, Po-Hsien Kuo, Ming-Jui Tsai, Yi-Jie Chen, Guei-Chi Li, Shu-Yuan Ho, Hui-Hou Chen, Yu-Shan Huang, Chien-Ching Hung, Yee-Chun Chen, Sui-Yuan Chang, Shan-Chwen Chang

    Published 2023-08-01
    Get full text
    Article
  7. 7
    A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

    A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant by Yi‐Chung Chang, Chi‐Fan Yang, Yi‐Fen Chen, Chia‐Chun Yang, Yuan‐Lin Chou, Hung‐Wen Chou, Tein‐Yao Chang, Tai‐Ling Chao, Shu‐Chen Hsu, Si‐Man Ieong, Ya‐Min Tsai, Ping‐Cheng Liu, Yuan‐Fan Chin, Jun‐Tung Fang, Han‐Chieh Kao, Hsuan‐Ying Lu, Jia‐Yu Chang, Ren‐Shiuan Weng, Qian‐Wen Tu, Fang‐Yu Chang, Kuo‐Yen Huang, Tong‐Young Lee, Sui‐Yuan Chang, Pan‐Chyr Yang

    Published 2022-04-01
    Get full text
    Article

Search Tools: